Detalhe da pesquisa
1.
Meta-Analysis of 49 Roche Oncology Trials Comparing Blinded Independent Central Review (BICR) and Local Evaluation to Assess the Value of BICR.
Oncologist
; 2023 Mar 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36905580
2.
Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels.
J Clin Invest
; 116(9): 2552-61, 2006 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-16955146
3.
Identification of residues crucially involved in soluble guanylate cyclase activation.
FEBS Lett
; 580(17): 4205-13, 2006 Jul 24.
Artigo
Inglês
| MEDLINE | ID: mdl-16831427
4.
NO-independent activation of soluble guanylate cyclase prevents disease progression in rats with 5/6 nephrectomy.
Br J Pharmacol
; 148(6): 853-9, 2006 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-16770325
5.
Residues stabilizing the heme moiety of the nitric oxide sensor soluble guanylate cyclase.
Eur J Pharmacol
; 513(1-2): 67-74, 2005 Apr 18.
Artigo
Inglês
| MEDLINE | ID: mdl-15878710
6.
Dimerization region of soluble guanylate cyclase characterized by bimolecular fluorescence complementation in vivo.
Mol Pharmacol
; 72(5): 1181-90, 2007 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-17715400